Baxter
BAX
HK$225.29
Share price
-3.37%
Change (1 day)
-18.07%
Change (1 year)
Categories
Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
Baxter (BAX) - P/B ratio
P/B ratio as of July 2025 : 2.11
According to Baxter's latest financial reports the company has a price-to-book ratio of 1.24981.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Baxter - P/B ratio (from 2001 to 2025)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2025-12-31 | N/A | -100% |
| 2024-12-31 | 2.12 | -8.36% |
| 2023-12-31 | 2.32 | -46.86% |
| 2022-12-31 | 4.36 | -7.5% |
| 2021-12-31 | 4.71 | 0.32% |
| 2020-12-31 | 4.70 | -12.19% |
| 2019-12-31 | 5.35 | 24.62% |
| 2018-12-31 | 4.29 | 11.11% |
| 2017-12-31 | 3.86 | 32.64% |
| 2016-12-31 | 2.91 | 23.59% |
| 2015-12-31 | 2.36 | -51.64% |
| 2014-12-31 | 4.87 | 9.51% |
| 2013-12-31 | 4.45 | -14.7% |
| 2012-12-31 | 5.22 | 27.7% |
| 2011-12-31 | 4.09 | -5.54% |
| 2010-12-31 | 4.33 | -8.99% |
| 2009-12-31 | 4.75 | -10.92% |
| 2008-12-31 | 5.34 | 0.2% |
| 2007-12-31 | 5.33 | 10.68% |
| 2006-12-31 | 4.81 | -12.09% |
| 2005-12-31 | 5.47 | -5% |
| 2004-12-31 | 5.76 | 0.6% |
| 2003-12-31 | 5.73 | 0.26% |
| 2002-12-31 | 5.71 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 Cardinal Health CAH | -20.3 | -1,062.43% | 🇺🇸 USA |
 Stryker Corporation SYK | 7.12 | 237.89% | 🇺🇸 USA |
 Boston Scientific BSX | 6.81 | 223.10% | 🇺🇸 USA |
 Becton Dickinson BDX | 2.00 | -5.27% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | 14.7 | 596.11% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | 3.32 | 57.70% | 🇺🇸 USA |
 Owens & Minor
OMI | 1.08 | -48.85% | 🇺🇸 USA |
 Medtronic MDT | 2.39 | 13.30% | 🇮🇪 Ireland |
 ICU Medical
ICUI | 1.65 | -21.86% | 🇺🇸 USA |